SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Aprea Therapeutics Reports Q3 EPS of USD -0.09

Valid market news retained in the public archive without immediate LiveCast distribution.

APRE
SquawkNews Desk 1 updates Updated Nov 04, 2026, 01:33 PM UTC

Story updates

01:33:29 PM UTC
SquawkNews
APREA THERAPEUTICS Q3 OPERATING INCOME USD -5.2 MILLION

Related stories

Merlin Properties Raises 2026 FFO Guidance to EUR 0.58 per Share Merlin Properties raised its 2026 FFO guidance to EUR 0.58 per share and updated its strategy for its 704 MW data center portfolio. M impact | EARNINGS | Nov 14, 2026, 08:03 PM UTC Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million Lucara Diamond raised L impact | EARNINGS | Nov 14, 2026, 01:10 AM UTC Gilead Expects HIV Revenue to Grow About 12% in 2026 Gilead expects HIV revenue to grow about 12% in fiscal 2026. M impact | EARNINGS | Nov 14, 2026, 12:44 AM UTC Asante Gold Withdraws 2026 Production and Cost Guidance Asante withdrew its 2026 guidance for 275,000–300,000 equivalent ounces at consolidated AISC of $3,200–$3,600/oz after Bibiani underperformed. Nine-month production was 165,594 equ M impact | EARNINGS | Nov 13, 2026, 11:27 PM UTC Japan's FiEE 9M Revenue More Than Quadruples FiEE's nine-month revenue more than quadrupled, attributed to SaaS expansion. M impact | EARNINGS | Nov 13, 2026, 10:28 PM UTC Equity Index futures dip on tech selling, hold weekly gains. Equity Index futures traded lower on Friday as technology sector weakness and rising yields weighed on markets, though major indices remained on track for weekly gains. E-mini S&P H impact | EARNINGS | Nov 13, 2026, 10:00 PM UTC